Viome Life Sciences

Viome Life Sciences is a Seattle-based life sciences company that focuses on microbiome analysis and diagnostics.

Facts

HQ
Seattle-area
Sectors
Wellness, Diagnostics, Microbiome, At-home testing

Viome raises $86.5M Series C and partners with CVS to sell $179 at-home Full Body Intelligence gut test in 200 stores

Seattle-area health tech startup Viome Life Sciences raised an $86.5 million Series C and struck a deal to sell its $179 at-home Full Body Intelligence gut microbiome test in 200 CVS stores and online. Founded by Naveen Jain, Viome analyzes stool, saliva and blood samples and counts investors including Marc Benioff and Khosla Ventures, though some scientists question clinical utility of microbiome kits.

Nordstrom to sell Viome’s $199 Health Intelligence microbiome test online and in select stores in 2022

Nordstrom will sell Viome Life Sciences’ Viome Health Intelligence microbiome test for $199 online and in select stores in 2022, with the kit requiring a stool sample. Viome sequences RNA to profile gut microbes and offers AI-driven diet/supplement recommendations plus a $149/month supplement service, though its clinical claims rely on non–peer-reviewed data and have drawn outside skepticism.

Viome Life Sciences splits into Viome Consumer Services and Viome Health Sciences to separate products from diagnostics and therapeutics

Viome, now Viome Life Sciences, has split into two divisions: Viome Consumer Services for individualized diet and supplement products, and Viome Health Sciences to develop diagnostics, predictive biomarkers and therapeutics for chronic disease and cancer. The Bellevue startup, led by CEO Naveen Jain and backed by investors including Marc Benioff, has over 200,000 customers and expects $100 million in revenue next year.

People

Online